CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
129,294
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 67,088
|
$ 271,477
|
$ 1,293
|
$ 7,388,061
|
$ (34,518)
|
$ (7,287,748)
|
$ 271,477
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings (in shares) |
|
|
423
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings |
50,985
|
|
$ 4
|
50,981
|
|
|
|
| Issuance of common stock under equity plans (in shares) |
|
|
594
|
|
|
|
|
| Issuance of common stock under equity plans |
0
|
|
$ 6
|
(6)
|
|
|
|
| Stock-based compensation |
57,840
|
|
|
57,840
|
|
|
|
| Other comprehensive income (loss) |
(2,999)
|
|
|
|
(2,999)
|
|
|
| Net income (loss) |
(18,251)
|
|
|
|
|
(18,251)
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
130,311
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
426,140
|
|
$ 1,303
|
7,496,876
|
(37,517)
|
(7,034,522)
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
129,294
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
67,088
|
$ 271,477
|
$ 1,293
|
7,388,061
|
(34,518)
|
(7,287,748)
|
$ 271,477
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Purchases of capped calls related to convertible senior notes |
35,311
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
12,743
|
|
|
|
|
|
|
| Net income (loss) |
202,204
|
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
|
|
131,791
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
580,247
|
|
$ 1,318
|
7,414,771
|
(21,775)
|
(6,814,067)
|
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
130,311
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
426,140
|
|
$ 1,303
|
7,496,876
|
(37,517)
|
(7,034,522)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings (in shares) |
|
|
556
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings |
81,061
|
|
$ 6
|
81,055
|
|
|
|
| Issuance of common stock under equity plans (in shares) |
|
|
110
|
|
|
|
|
| Issuance of common stock under equity plans |
0
|
|
$ 1
|
(1)
|
|
|
|
| Stock-based compensation |
112,807
|
|
|
112,807
|
|
|
|
| Other comprehensive income (loss) |
7,565
|
|
|
|
7,565
|
|
|
| Net income (loss) |
(72,228)
|
|
|
|
|
(72,228)
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
130,977
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
555,345
|
|
$ 1,310
|
7,690,737
|
(29,952)
|
(7,106,750)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings (in shares) |
|
|
625
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings |
80,420
|
|
$ 6
|
80,414
|
|
|
|
| Issuance of common stock under equity plans (in shares) |
|
|
189
|
|
|
|
|
| Issuance of common stock under equity plans |
0
|
|
$ 2
|
(2)
|
|
|
|
| Stock-based compensation |
109,339
|
|
|
109,339
|
|
|
|
| Purchases of capped calls related to convertible senior notes |
(430,406)
|
|
|
(430,406)
|
|
|
|
| Purchase of capped calls related to —% Convertible Senior Notes due 2028 |
(35,311)
|
|
|
(35,311)
|
|
|
|
| Other comprehensive income (loss) |
8,177
|
|
|
|
8,177
|
|
|
| Net income (loss) |
292,683
|
|
|
|
|
292,683
|
|
| Ending balance (in shares) at Sep. 30, 2025 |
|
|
131,791
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 580,247
|
|
$ 1,318
|
7,414,771
|
(21,775)
|
(6,814,067)
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
132,376
|
|
132,376
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ 789,176
|
|
$ 1,324
|
7,510,473
|
(20,097)
|
(6,702,524)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings (in shares) |
|
|
102
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings |
13,751
|
|
$ 1
|
13,750
|
|
|
|
| Issuance of common stock under equity plans (in shares) |
|
|
966
|
|
|
|
|
| Issuance of common stock under equity plans |
0
|
|
$ 9
|
(9)
|
|
|
|
| Stock-based compensation |
71,259
|
|
|
71,259
|
|
|
|
| Other comprehensive income (loss) |
(4,797)
|
|
|
|
(4,797)
|
|
|
| Net income (loss) |
205,991
|
|
|
|
|
205,991
|
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
133,444
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
$ 1,075,380
|
|
$ 1,334
|
7,595,473
|
(24,894)
|
(6,496,533)
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
132,376
|
|
132,376
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ 789,176
|
|
$ 1,324
|
7,510,473
|
(20,097)
|
(6,702,524)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Purchases of capped calls related to convertible senior notes |
0
|
|
|
|
|
|
|
| Other comprehensive income (loss) |
(24,564)
|
|
|
|
|
|
|
| Net income (loss) |
$ 2,537,820
|
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2026 |
133,875
|
|
133,875
|
|
|
|
|
| Ending balance at Sep. 30, 2026 |
$ 3,603,852
|
|
$ 1,339
|
7,811,878
|
(44,661)
|
(4,164,704)
|
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
133,444
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
1,075,380
|
|
$ 1,334
|
7,595,473
|
(24,894)
|
(6,496,533)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings (in shares) |
|
|
182
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings |
33,758
|
|
$ 2
|
33,756
|
|
|
|
| Issuance of common stock under equity plans (in shares) |
|
|
108
|
|
|
|
|
| Issuance of common stock under equity plans |
0
|
|
$ 1
|
(1)
|
|
|
|
| Stock-based compensation |
87,730
|
|
|
87,730
|
|
|
|
| Other comprehensive income (loss) |
(7,244)
|
|
|
|
(7,244)
|
|
|
| Net income (loss) |
164,494
|
|
|
|
|
164,494
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
|
133,734
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
1,354,118
|
|
$ 1,337
|
7,716,958
|
(32,138)
|
(6,332,039)
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings (in shares) |
|
|
103
|
|
|
|
|
| Exercise of common stock options, net of tax withholdings |
14,700
|
|
$ 2
|
14,698
|
|
|
|
| Issuance of common stock under equity plans (in shares) |
|
|
38
|
|
|
|
|
| Stock-based compensation |
80,222
|
|
|
80,222
|
|
|
|
| Other comprehensive income (loss) |
(12,523)
|
|
|
|
(12,523)
|
|
|
| Net income (loss) |
$ 2,167,335
|
|
|
|
|
2,167,335
|
|
| Ending balance (in shares) at Sep. 30, 2026 |
133,875
|
|
133,875
|
|
|
|
|
| Ending balance at Sep. 30, 2026 |
$ 3,603,852
|
|
$ 1,339
|
$ 7,811,878
|
$ (44,661)
|
$ (4,164,704)
|
|